Azul (NYSE: AZLUD) shifts ADS listing from OTC to NYSE American
Rhea-AI Filing Summary
Azul S.A. announced that its common shares and American depositary shares (ADSs), each representing two common shares, have been approved for listing on NYSE American. Subject to listing conditions, trading of the ADSs on NYSE American under the ticker "AZUL" is expected to begin on June 1, 2026, at market open.
Once this occurs, prices for the ADSs will no longer be quoted on OTC Markets. Azul’s common shares will continue to trade on Brazil’s B3 under the symbol AZUL3, and existing holders of common shares or ADSs are not required to take any action. The CEO described the NYSE American listing as an important milestone following the company’s restructuring and indicated Azul is on track to seek an uplisting to the New York Stock Exchange in early July 2026.
Positive
- None.
Negative
- None.
Insights
Azul shifts ADS trading from OTC to NYSE American, aiming later for NYSE.
Azul’s ADSs, each representing two common shares, have been approved for listing on NYSE American, with trading expected to start on June 1, 2026. This moves the ADSs from OTC Markets to a national securities exchange, while common shares remain on B3 as AZUL3.
The company frames this step as part of emerging from a restructuring on a stronger financial footing. Management also states it is on track to uplist to the New York Stock Exchange in early July 2026, contingent on satisfying all listing requirements and conditions.
Actual impact will depend on execution of the NYSE American listing on June 1, 2026 and any subsequent confirmation of an NYSE uplisting. Future disclosures may clarify progress on meeting the additional NYSE requirements and the final timing.